Detalhe da pesquisa
1.
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
J Autoimmun
; 95: 1-14, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446251
2.
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.
PLoS Med
; 13(10): e1002139, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27727279
3.
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
J Autoimmun
; 56: 66-80, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25457307
4.
CD56bright natural killer cells preferentially kill proliferating CD4+ T cells.
Discov Immunol
; 2(1): kyad012, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649552
5.
Medicine thrives on experience from abroad.
BMJ
; 355: i5699, 2016 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784707